BDBM742438 N-(1R,4R)-[4-[2-cyano- 4-methyl-5-[[2-[6- (2,2,2-trifluoroethyl) quinazolin-4-yl]-2,7- diazaspiro[3.5]nonan- 7-yl]methyl]indol-1- yl]methyl]cyclohexyl] methanesulfonamide Example 26::US20250163061, Compound 40

SMILES Cc1c(CN2CCC3(CC2)CN(c2ncnc4ccc(CC(F)(F)F)cc24)C3)ccc2c1cc(C#N)n2C[C@H]1CC[C@H](NS(C)(=O)=O)CC1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 742438   

TargetMenin(Human)
Bala Therapeutics

US Patent
LigandPNGBDBM742438(N-(1R,4R)-[4-[2-cyano- 4-methyl-5-[[2-[6- (2,2,2-t...)
Affinity DataEC50: <75nMAssay Description:Compound activity was determined using recombinant MEN1 protein (Creativebiomart, Cat #MEN1-35H) and a custom fluorescein-labeled MLL4-43 peptide (Et...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
9/19/2025
Entry Details
US Patent